comparemela.com

StockNews.com cut shares of Abeona Therapeutics (NASDAQ:ABEO – Free Report) from a hold rating to a sell rating in a research report sent to investors on Tuesday morning. Abeona Therapeutics Price Performance NASDAQ ABEO opened at $3.26 on Tuesday. Abeona Therapeutics has a fifty-two week low of $2.83 and a fifty-two week high of $9.01. […]

Related Keywords

Brendanm Omalley , ,Barclays Plc ,Schonfeld Strategic Advisors ,Abeona Therapeutics Company Profile ,Capital Management ,Citigroup Inc ,Abeona Therapeutics Inc ,Abeona Therapeutics ,Free Report ,Get Free Report ,Capital Partners ,Therapeutics Inc ,Abeona Therapeutics Daily ,Nasdaq Abeo ,Labeo ,Medical ,Downgrade ,Stocknews Com ,

© 2025 Vimarsana

comparemela.com © 2020. All Rights Reserved.